ProductProductWhat are Generics?
Zetia
view photo
Generic Zetia Ezetimibe 10mg

Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy.


Cholesterol


PackagePricePer pillSavingsOrder
10mg × 30 pills$44.99$ 1.50 
10mg × 60 pills$79.99$ 1.33  $9.99
10mg × 90 pills$114.99$ 1.28  $19.98
10mg × 120 pills$149.99$ 1.25  $29.97
10mg × 180 pills$219.99$ 1.22  $49.95
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
You have been fabulous to work with and I will clearly recommend your service and use it again myself.
Read more »Read more »
NewsNews
    Strong profit growth and Zetia patent win for Merck & Co - Pharma Times
    Strong profit growth and Zetia patent win for Merck & CoPharma TimesMerck & Co's first-quarter earnings have been boosted by good performances from diabetes drugs Januvia and Janumet, the cholesterol drug Zetia and the cervical cancer vaccine Gardasil
    Did FDA's Vytorin warning negatively impact health outcomes? - Medical Marketing and Media
    Did FDA's Vytorin warning negatively impact health outcomes?Medical Marketing and MediaResearchers keyed in on an FDA communication to clinicians issued January 25, 2008, regarding ezetimibe (known as either Zetia or the ezetimibe-simvastatin combination, Vytorin)
    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin
    CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate ... - MarketWatch (press release)
    CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate
    Stocks to watch Monday: Haemonetics, Merck - MarketWatch
    Stocks to watch Monday: Haemonetics, MerckMarketWatchCulminating more than two years of litigation, Merck (NYSE:MRK) said late Friday a federal court ruled in a patent case involving Zetia and Vytorin, saying that a patent held on an active ingredient in both drugs was enforceable and would remain in
Live support Online Chat


Our billing is certified by
Secure shopping certificates